23.12.2022 - Bayerische Beteiligungsgesellschaft joins other business angels in investing in the gate-startup neurotrim Systems. The healthcare startup develops solutions for prevention, rehabilitation and therapy of orthopedic injuries.
neurotrim Systems, founded by Maximilian Schiff and Rebekka Mirlach, has received funding in the past from the BMWi’s EXIST startup grant, among others, and has now secured investments from BayBG and other business angels.
These investments are an important milestone for the startup, which offers prevention, rehabilitation and performance monitoring services to professional sports clubs, athletes and rehabilitation centers. These services include the use of the neurotrim System’s newly developed “N1.System,” an ML-powered hardware-software solution that provides personalized and objective therapy and training approaches.
“We are incredibly grateful for the support of BayBG and the other investors,”
said CEO Maximilian Schiff.
“The investments will enable us to launch the N1.System in 2023 and take further big steps. Thus, the foundation of our financing is in place and we are only on the lookout for further strategic investment partners. After the difficult development phase due to the pandemic and the economic situation, we are very proud of our team, the progress and this milestone.”